SCHEMBL27136207

SCHEMBL27136207

COC(=O)C(CC1CCCCC1)NC(=O)CCCO

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRM1 Q13255 1/20 0.45
GRN P28799 1/20 0.39
SORT1 Q99523 1/20 0.39
NMT1 P30419 5/20 0.38
NMT2 O60551 4/20 0.38
CTSK P43235 4/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26985789 1.00 CHRNB2 (0.45) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
SCHEMBL4241732 0.82 GRN (0.40) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
SCHEMBL28563624 0.82 GRN (0.40) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
Hydrochloric Acid SCHEMBL15543179 0.81 CHRNB2 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
Hydrochloric Acid SCHEMBL15543180 0.81 CHRNB2 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
SCHEMBL23052492 0.80 REN (0.44) GRNSORT1CTSKCTSLCTSB
SCHEMBL25523633 0.80 CTSK (0.45) GRNSORT1CTSKCTSLCTSB
SCHEMBL28563558 0.79 CHRNB2 (0.39) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
SCHEMBL31505876 0.77 CTSS (0.49) CTSKCTSLCTSBCTSSHDAC1
SCHEMBL4114002 0.77 GRN (0.36) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 US disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS BCL2, BCL2A1, BAX CHRNB2 3901/4885CHRNB4 4291/4885CHRNA3 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.